CXT

Analyst Note: Crane NXT (CXT)

Date: 2026-06-13 Price: $46.93

1. Structural Readiness

• Conservative Entry: Not yet defined (requires a confirmed breakout).
• Aggressive/Pre-Breakout Entry: Not actionable on its own; requires confirmation.
• Breakout Level: Not yet established.
• Current Price: $46.93.
• Extension: Not applicable (price is not in an extended post-breakout phase).
• ATR Context: Current ATR is 4.3% (High). This indicates elevated volatility, which is within the historical "sweet spot" (4–6%) for structural quality, suggesting the setup has sufficient momentum to move but requires careful position sizing.

2. Thesis Layer

As of 2026-06-13, there is no named secular thesis attached to this setup. This is a TACTICAL, setup-led name. The conviction must be derived strictly from the quality of the structural setup (the forming coil) and the immediate business fundamentals disclosed in the recent earnings and filings. We do not invent a macro thesis; we judge the name on its ability to execute the growth trajectory management has outlined and the technical structure's readiness to capture that value.

3. Business Overview

Crane NXT is a premier industrial technology company providing proprietary solutions for security, detection, and authentication. The company operates in the Materials sector, specifically within the Authentication and Security industry.

Key Business Drivers & Evidence (as of May/June 2026):

• Strategic Acquisition: The company completed a multi-phase acquisition of Antares Vision S.p.A. on March 31, 2026, resulting in 100% ownership. Antares Vision is a global provider of inspection, detection, and track-and-trace solutions for life sciences and food and beverage markets.
• *Evidence:* [E8], [E9], [E6].
• Revenue Impact: Antares Vision is expected to contribute approximately $200 million to $210 million of revenue for the nine months of 2026, with Q4 being the highest quarter.
• *Evidence:* [E3].
• Segment Performance:
• Digital Transformation Technologies (DTT): Management expects sales growth in the low 20s percent for 2026, inclusive of Antares Vision.
• *Evidence:* [E4].
• CPI (Consumer Products & Identification): Backlog is approximately $120 million, reflecting 8% sequential growth and a book-to-bill ratio of 1.0.
• *Evidence:* [E2].
• Banknote and Security Products: Sales increased 50.3% to $140.4 million in the period ended March 31, 2026, driven by organic growth of 39.6%.
• *Evidence:* [E12], [E13].
• Backlog Visibility: Over 90% of sales for 2026 are currently in backlog, providing high confidence in near-term revenue realization.
• *Evidence:* [E7].
• Profitability: Management expects full-year adjusted segment EBITDA margins to be approximately 27%, including the Antares Vision contribution.
• *Evidence:* [E5].

4. Archetype and Conviction

• Archetype: Growth Leader.
• *Fit:* The company is demonstrating rapid top-line expansion (51.3% sales increase in the CPI segment, 50.3% in Banknotes) driven by both organic growth and a major accretive acquisition. The high backlog visibility and margin expansion expectations (27%) align with a Growth Leader profile rather than a cyclical recovery or deep value play.
• Valuation Context:
• Forward consensus EPS for FY1 is $4.23 and FY2 is $4.73.
• At a current price of $46.93, the stock trades at approximately 11.1x FY1 and 9.9x FY2 earnings.
• *Evidence:* [E25].
• Conviction Stack:
• Thesis Strength: Moderate (Tactical, no macro thesis).
• Evidence Quality: High. Recent filings and transcripts provide specific, quantified guidance on backlog, revenue contribution from Antares, and margin targets.
• Structural Quality: The ATR of 4.3% suggests a healthy, active market environment for the stock, suitable for a forming coil.
• Rerating Potential: High, contingent on the successful integration of Antares and the realization of the 27% margin target.

5. Invalidations, Strengths, and Gaps

• What Would Strengthen the Case:
• A confirmed close above the structural resistance (breakout) on the forming coil.
• Management reiterating or raising the 2026 revenue guidance for Antares Vision beyond the $200M-$210M range.
• Confirmation that the $123.5 million of assumed Antares debt is paid down as scheduled in Q2 2026 without liquidity strain.
• *Evidence:* [E10], [E3].
• What Would Invalidate the Case:
• A significant miss on the 2026 backlog conversion or a drop in the book-to-bill ratio below 1.0.
• Failure to achieve the 27% EBITDA margin target due to integration costs or margin compression.
• Gaps in Evidence:
• Debt Service Details: While the debt assumption is noted, the specific impact on interest expense and cash flow post-Q2 2026 is not detailed in the provided snippets.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: 90% of 2026 sales are in backlog with high confidence; Antares Vision acquisition completed March 31, 2026, adding $200M-$210M revenue; CPI backlog grew 8% sequentially with 1.0 book-to-bill ratio. Key risks: Integration execution risk for Antares Vision; elevated volatility (4.3% ATR) may lead to false breakouts; geopolitical monitoring of Middle East conflict affecting global operations; debt load from acquisition ($366.9M term loan + $123.5M assumed debt). Sizing hint: Position size should account for the "forming" status (partial readiness) and high ATR; do not size as a confirmed breakout. Expected path: Management expects Antares to drive low-20s% DTT growth and 27% EBITDA margins; price likely to test structural resistance as Q2 results confirm backlog conversion. Expected horizon: 3 to 6 months for the forming coil to resolve into a confirmed breakout or invalidation.